Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Update

Polyrizon Ltd. (NASDAQ:PLRZGet Free Report) was the target of a significant decrease in short interest in April. As of April 30th, there was short interest totaling 35,463 shares, a decrease of 47.2% from the April 15th total of 67,203 shares. Approximately 1.9% of the shares of the company are sold short. Based on an average daily trading volume, of 70,232 shares, the days-to-cover ratio is currently 0.5 days.

Hedge Funds Weigh In On Polyrizon

A hedge fund recently bought a new stake in Polyrizon stock. Jane Street Group LLC acquired a new position in Polyrizon Ltd. (NASDAQ:PLRZFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned 1.35% of Polyrizon as of its most recent SEC filing.

Polyrizon Stock Performance

Shares of NASDAQ PLRZ traded down $1.09 during mid-day trading on Monday, reaching $13.71. The company’s stock had a trading volume of 20,889 shares, compared to its average volume of 72,271. The stock has a fifty day moving average of $13.49 and a two-hundred day moving average of $11.46. Polyrizon has a 52 week low of $2.88 and a 52 week high of $18.20.

Polyrizon (NASDAQ:PLRZGet Free Report) last released its quarterly earnings data on Saturday, February 14th. The company reported ($2.81) earnings per share for the quarter.

Analyst Upgrades and Downgrades

PLRZ has been the subject of a number of analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Polyrizon in a research report on Monday, May 4th. Wall Street Zen upgraded Polyrizon from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

Check Out Our Latest Stock Analysis on PLRZ

About Polyrizon

(Get Free Report)

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Read More

Receive News & Ratings for Polyrizon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polyrizon and related companies with MarketBeat.com's FREE daily email newsletter.